Elevra Lithium Signs MoU for Spodumene Offtake, Covering 46% of Future Sales

summarizeSummary

Elevra Lithium signed a non-binding MoU with Mangrove Lithium to potentially supply up to 144,000 tonnes per year of spodumene concentrate, covering approximately 46% of its estimated future sales volumes.

check_boxKey Events

• Major Offtake Potential

  Elevra Lithium signed a non-binding Memorandum of Understanding (MoU) to potentially supply up to 144,000 tonnes per year of spodumene concentrate to Mangrove Lithium.

• Significant Sales Volume

  The proposed supply represents approximately 46% of Elevra's estimated sales volumes from its North American Lithium (NAL) project.

• Long-Term Supply & Price Stability

  The proposed supply is for an initial five-year period, commencing in 2028, and includes market-related pricing with a floor and ceiling to support cashflow generation across market cycles.

• Strategic Local Partnership

  This collaboration supports the establishment of a resilient, domestic battery supply chain in Canada, potentially reducing Elevra's freight and logistics costs by supplying a local converter.

auto_awesomeAnalysis

This non-binding Memorandum of Understanding with Mangrove Lithium is a significant commercial development for Elevra Lithium. It outlines the potential supply of up to 144,000 tonnes per year of spodumene concentrate, representing approximately 46% of Elevra's estimated sales volumes from its North American Lithium project. The agreement, if finalized, would provide a stable, long-term revenue stream with a floor and ceiling price mechanism, enhancing cashflow predictability. This strategic partnership also supports local processing in Canada, potentially reducing logistics costs and aligning with government initiatives for a domestic battery supply chain. Investors should monitor the progress towards a definitive agreement, which is contingent on Mangrove's final investment decision by June 2027.